Author

Joerg Windsheimer

OpenAlex ID: A5000648697

Real-world Efficacy of Delayed-Release Dimethyl Fumarate in Early Multiple Sclerosis: Interim Results from ESTEEM

2019 · Kathryn Giles, Konstantin Balashov, et al. · 4

Real-world Efficacy of Delayed-Release Dimethyl Fumarate in Early Multiple Sclerosis: Interim Results from ESTEEM (P3.2-081)

2019 · Kathryn Giles, Konstantin Balashov, et al. · Neurology · 2

099 Safety and effectiveness of dimethyl fumarate in multiple sclerosis patients treated over 5 years

2022 · Kathryn Giles, Konstatin Balashov, et al. · Journal of Neurology Neurosurgery & Psychiatry

Efficacy of Delayed-Release Dimethyl Fumarate in Newly Diagnosed and Other Early Multiple Sclerosis Patients, and Patients Switching from Interferon or Glatiramer Acetate, in Routine Medical Practice: Interim Results from ESTEEM (P1.367)

2018 · Kathryn Giles, Jerome Hanna, et al. · Neurology

Works count: 4

Citation count: 6

H-index: 2

I10-index: